Observational analysis identifies the CALLY index's role in predicting IVIG non-response in Kawasaki disease, suggesting its potential clinical utility.
Background The CRP–albumin–lymphocyte (CALLY) index has been demonstrated to be a predictive tool for tumors. However, studies on its role and clinical significance in predicting intravenous immunoglobulin (IVIG) non-response in patients with Kawasaki disease (KD) remains limited.
No takes yet. Share an insight, caveat, or question.
Duan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: